Report
Louis AZAIS
EUR 104.42 For Business Accounts Only

Analyse court terme - VIRBAC SA : La moyenne mobile sert de résistance.

Les sommets et les creux ne sont pas particulièrement inclinés, la tendance est neutre. Les cours consolident.

Arguments :
- Le support majeur est atteint, il cause le rebond.
- La résistance majeure est atteinte, elle cause le repli.
- La moyenne mobile sert de résistance.
- Le gap a été fermé, le signal est affaibli.
Underlying
Virbac SA

Virbac is an independent veterinary pharmaceutical laboratory. Co. develops and provides veterinarians and farmers with medicines and vaccines that improve the health of food producing animals. Co. markets a range of products designed for pets and livestock. It offers seven types of products for companion animals (Parasiticides, Immunology, Antibiotics/dermatology, Specialties, Equine, Specialized pet food and Other products), and four types of products for food producing animals (Bovine parasiticides, Bovine products (excluding parasiticides), Pig/poultry antibiotics and Other products). Co. markets its products in the ethical (veterinarian) and OTC markets.

Provider
Day By Day
Day By Day

​​DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.

Analysts
Louis AZAIS

Other Reports on these Companies
Other Reports from Day By Day

ResearchPool Subscriptions

Get the most out of your insights

Get in touch